FDA Adverse Event Malfunction Summary report: N

STERRAD 100NX STERILIZER

MDR report key: 2972651 · Received February 21, 2013

Report

Report Number
2084725-2013-00069
Event Type
Malfunction
Date Received
February 21, 2013
Date of Event
February 8, 2013
Report Date
February 8, 2013
Manufacturer
ADVANCED STERILIZATION PRODUCTS
Product Code
MLR
PMA / PMN Number
K071385
Removal / Correction Number
Z-1026-1027-2013
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A FIELD SERVICE ENGINEER WAS DISPATCHED TO CUSTOMER SITE. ODOR/SMELL WAS CONFIRMED. THE CATALYTIC DECOMP FILTER AND OIL MIST FILTER WERE REPLACED. UNIT MEETS SPECIFICATIONS AND WAS RETURNED TO SERVICE ON (B)(4) 2013.

Additional Manufacturer Narrative · 1

MANUFACTURER DATE: MAY 29, 2008. CONCLUSION: ROOT CAUSE IDENTIFIED IN CAPA WAS FOUND TO BE PREMATURE FAILURE/SATURATED OIL MIST FILTER OR VACUUM PUMP OIL. ASP INVESTIGATION SUMMARY: THE INVESTIGATION INCLUDED A REVIEW OF THE DEVICE HISTORY RECORD, SERVICE HISTORY, TRENDING OF THE PRODUCT MALFUNCTION CODE, FAILURE MODE AND EFFECTS ANALYSIS, HEALTH HAZARD EVALUATION, SYSTEM HAZARD AND USER MISUSE ANALYSIS, AND CAPA. THE DHR (DEVICE HISTORY RECORD) WAS REVIEWED AND NO ISSUES REGARDING THE FAILURE MODE WERE NOTED. THE INVOLVED UNIT MET MANUFACTURER SPECIFICATIONS AT THE TIME OF RELEASE. THE SERVICE HISTORY FOR THIS UNIT FOR THE PAST 6 MONTHS (08/12/2012 TO 02/08/2013), DID NOT REVEAL A SIGNIFICANT TREND FOR THIS SAME ISSUE. THE TREND OF THE PRODUCT MALFUNCTION CODE ODOR/SMELLS WAS COMPLETED FROM MARCH 2012 THROUGH FEBRUARY 2013 AND REVEALED A SIGNIFICANT TREND WHICH WAS ADDRESSED THROUGH CAPA. THE TREND OF THE PRODUCT MALFUNCTION CODE HUMAN REACTION WAS COMPLETED FROM MARCH 2012 THROUGH FEBRUARY 2013. THE OVER ALL THE RISK IS CONSIDERED TO BE "AS LOW AS REASONABLY PRACTICABLE". THE FMEA (FAILURE MODE AND EFFECTS ANALYSIS) REVEALED THE RISK PRIORITY NUMBER SCORES ARE BELOW 100 AND ARE CONSIDERED ACCEPTABLE. THE HHE (HEALTH HAZARD EVALUATION) WAS REVIEWED FOR THE RISK OF ODOR AND SMELL EXPOSURE. THE SEVERITY AND OCCURRENCE FOR THE GENERAL POPULATION WERE LIMITED (TRANSIENT, MINOR IMPAIRMENT, NO MEDICAL TREATMENT REQUIRED) AND THE PRODUCT PROBLEM HAS BEEN KNOWN TO RESULT IN THE IDENTIFIED HARM DOCUMENTED OR REPORTED IN CLINICAL PRACTICE, BUT ONLY OCCASIONALLY AND/OR UNDER UNUSUAL CIRCUMSTANCES. THE SHUMA (SYSTEM HAZARD AND USER MISUSE ANALYSIS) SHOWS THAT THE RISK IS AS LOW AS REASONABLY PRACTICAL FOR EXPOSURE TO ODOR OR ODORANTS. THE CAPA (CORRECTIVE AND PREVENTATIVE ACTION) IDENTIFIED THE ROOT CAUSE FOR THE ODOR/SMELLS ISSUE AS: (1) PREMATURE FAILURE OF THE USED AND SATURATED STERRAD® 100NX OIL MIST FILTER CAUSED OIL VAPOR EMISSIONS THAT EXACERBATED THE ODOR/SMELL COMPLAINTS REPORTED FOR THE STERRAD® 100NX SYSTEM. (2) THE USE OF A LESS OXIDATIVELY STABLE VACUUM PUMP OIL CAUSED THE ODOR/SMELLS FOR THE STERRAD® 100NX SYSTEM. THE CATALYTIC FILTER AND THE SOLBERG FILTER WERE RETURNED AND TESTED. VISUAL ANALYSIS FOUND NO DAMAGE ON THE CATALYTIC FILTER OR THE SOLBERG FILTER. THE CATALYTIC FILTER WAS INSTALLED INTO THE TEST UNIT. DURING PUMPDOWN, THERE WAS A SLIGHT ODOR BEING EMITTED. THE REASON FOR RETURN IS CONFIRMED. THE OIL MIST FILTER WAS INSTALLED INTO THE TEST UNIT. DURING PUMPDOWN AN OIL MIST WAS BEING EMITTED. THE REASON FOR RETURN IS CONFIRMED.

Description of Event or Problem · 1

A CUSTOMER REPORTED AN EVENT OF ODOR EMITTING FROM THE STERRAD 100NX STERILIZER. ONE HCW REPORTED A REACTION OF A "BURNING SENSATION TO THE EYES" LASTING "A FEW MINUTES." THE HCW DID NOT RECEIVE ANY MEDICAL ATTENTION/TREATMENT AND HAS RECOVERED FROM HER SYMPTOMS. AN ASP FIELD SERVICE ENGINEER WAS DISPATCHED TO ASSESS THE UNIT ONSITE. THIS EVENT IS BEING REPORTED AS A MALFUNCTION REPORT SUBSEQUENT TO A SERIOUS INJURY EVENT DATED (B)(6) 2012.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
76148 STERRAD 100NX STERILIZER STERRAD EQUIPMENT (MLR) MLR ADVANCED STERILIZATION PRODUCTS NA

Patients

Seq Age Sex Outcome Treatment
1